Marinho 2021

Current Status of Trial
Completed
Study Aim
Treatment Dementia
Study Design
RCT
Blinding
Single-blind
Intervention type
Non-pharmacological
Intervention
Cognitive stimulation (CST)
Dosage and Duration
A single-blind design was used, with participants being randomly allocated to either 14 sessions of CST + treatment as usual (TAU; n = 23) or TAU (n = 24) during 7 weeks.
Absolute Number of Participants
47
Health Status/Diagnosis
Dementia
Co-morbid Health Condition/Other Participant Characteristics
Mild to moderate dementia
Primary outcomes
Cognition // Quality of life // Depression
Key Points
"pwD receiving CST and their family caregivers expressed good acceptance of the intervention, with low attrition and high attendance. Participants receiving CST exhibited significant improvements in mood and in activities of daily living compared to TAU. There were no significant effects in cognition, quality of life and caregiver burden." Marinho 2021